Collaborative health systems ECHO: The use of a tele-education platform to facilitate communication and collaboration with recipients of state targeted response funds in Pennsylvania

References

• Centers for Disease Control and Prevention. Drug Overdose Deaths – 2019. [Webpage]. https://www.cdc.gov/drugoverdose/data/statedeaths.html/. Accessed August 8, 2021.
   Google Scholar
• Centers for Disease Control and Prevention. Drug Overdose Death Data – 2016 [Webpage]. https://www.cdc.gov/drugoverdose/data/statedeaths.html/. Accessed February 16, 2017.
   Google Scholar
• Pennsylvania Department of Health. Results from the Fatal and Non-Fatal Drug Overdoses in Pennyslvania – 2019. Harrisburg, PA: Pennsylvania Department of Health; 2019.
   Google Scholar
• Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies-tackling the opioid-overdose epidemic. N Engl J Med. 2014;370(22):2063–2066.
   PubMed Web of Science ®Google Scholar
• Lee JD, Friedmann PD, Kinlock TW, et al. Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med. 2016;374(13):1232–1242.
   PubMed Web of Science ®Google Scholar
• Schwartz RP, Gryczynski J, O’Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health. 2013; 103(5):917–922.
   PubMed Web of Science ®Google Scholar
• Grönbladh L, Öhlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand. 1990;82(3):223–227.
   PubMed Web of Science ®Google Scholar
• Newman R, Whitehill W. Double-blind comparison of methadone and placebo maintenace treatments of narcotic addicts in Hong Kong. The Lancet. 1979;314(8141):485–488.
   Google Scholar
• Rieckmann T, Muench J, McBurnie MA, et al. Medication-assisted treatment for substance use disorders within a national community health center research network. Subst Abus. 2016;37(4):625–634.
   PubMed Web of Science ®Google Scholar
• Stoller KB, Stephens MAC, Schorr A. Integrated service delivery models for opioid treatment programs in an era of increasing opioid addiction, Health Reform, and Parity. 2016. http://www.aatod.org/wp-content/uploads/2016/07/2nd-Whitepaper-.pdf/.
   Google Scholar
• Substance Abuse and Mental Health Services, Office of the Surgeon G. Reports of the surgeon general. In: Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: US Department of Health and Human Services; 2016.
   Google Scholar
• Shields AE, Shin P, Leu MG, et al. Adoption of health information technology in community health centers: results of a national survey. Health Aff. 2007;26(5):1373–1383.
   Web of Science ®Google Scholar
• Brooklyn JR, Sigmon SC. Vermont hub-and-spoke model of care for opioid use disorder: development, implementation, and impact. J Addict Med. 2017;11(4):286–292.
   PubMed Web of Science ®Google Scholar
• Casper KL, Folland A. Models of Integrated Patient Care Through OTPs and DATA 2000; Practices. American Association for the Treatment of Opioid Dependence, 2016. http://www.njamha.org/links/publicpolicy/AATOD_whitepaper1.pdf.
   Google Scholar
• Anderson JB, Martin SA, Gadomski A, et al. Project ECHO and primary care buprenorphine treatment for opioid use disorder: implementation and clinical outcomes. Subst Abus. 2021;2021:1–9.
   Google Scholar
• Komaromy M, Duhigg D, Metcalf A, et al. Project ECHO (Extension for Community Healthcare Outcomes): a new model for educating primary care providers about treatment of substance use disorders. Subst Abus. 2016;37(1):20–24.
   PubMed Web of Science ®Google Scholar
• Puckett HM, Bossaller JS, Sheets LR. The impact of Project ECHO on physician preparedness to treat opioid use disorder: a systematic review. Addict Sci Clin Pract. 2021;16(1):6.
   PubMed Web of Science ®Google Scholar
• Holmes CM, Keyser-Marcus L, Dave B, Mishra V. Project ECHO and opiod education: a systematic review. Curr Treat Options Psych. 2020;7(1):9–22.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. T1-170-017 Individual Grant Awards, 2017. https://www.samhsa.gov/grants/awards/2017/TI-17-017.
   Google Scholar
• Arora S, Thornton K, Komaromy M, Kalishman S, Katzman J, Duhigg D. Demonopolizing medical knowledge. Acad Med. 2014;89(1):30–32.
   PubMed Web of Science ®Google Scholar
• Kawasaki S, Francis E, Mills S, Buchberger G, Hogentogler R, Kraschnewski J. Multi-model implementation of evidence-based care in the treatment of opioid use disorder in Pennsylvania. J Subst Abuse Treat. 2019;106:58–64.
   PubMed Web of Science ®Google Scholar
• Vaismoradi M, Turunen H, Bondas T. Content analysis and thematic analysis: implications for conducting a qualitative descriptive study. Nurs Health Sci. 2013;15(3):398–405.
   PubMed Web of Science ®Google Scholar
• Agley J, Delong J, Janota A, Carson A, Roberts J, Maupome G. Reflections on Project ECHO: qualitative findings from five different ECHO programs. Med Educ Online. 2021;26(1):1936435.
   PubMed Web of Science ®Google Scholar
• Carlin L, Zhao J, Dubin R, Taenzer P, Sidrak H, Furlan A. Project ECHO telementoring intervention for managing chronic pain in Primary Care: insights from a qualitative study. Pain Med. 2018;19(6):1140–1146.
   PubMed Web of Science ®Google Scholar
• Ball S, Stryczek K, Stevenson L. A qualitative evaluation of the pain management VA-ECHO program using the RE-AIM framework: the participant’s perspective. Front Public Health. 2020;15(8):169.
   Google Scholar
• Shea CM, Gertner AK, Green SL. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: a qualitative study . Subst Abus. 2021;42(1):54–56.
   PubMed Web of Science ®Google Scholar
• Jacobson N, Horst J, Wilcox-Warren L, et al. Organizational facilitators and barriers to medication for opioid use disorder capacity expansion and use. J Behav Health Serv Res. 2020;47(4):439–448.
   PubMed Web of Science ®Google Scholar
• Cernasev A, Hohmeier KC, Frederick K, Jasmini H, Gatwood J. A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistance to treatment for substance use disorder. Exploratory Research in Clinical and Social Pharmacy. 2021;2:100029.
   PubMedGoogle Scholar
• Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45(1):1–10.
   PubMed Web of Science ®Google Scholar
• Jones CW, Christman Z, Smith CM, et al. Comparison between buprenorphine proivder availability and opioid deaths among US counties. J Subst Abuse Treat. 2018;93:1–25.
   PubMed Web of Science ®Google Scholar
• Jones EB, Staab EM, Wan W, et al. Addiction treatment capacity in health centers: the role of Medicaid Reimbursement and Targeted Grant Funding. Psychiatr Serv. 2020;71(7):684–690.
   PubMed Web of Science ®Google Scholar
• Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Sust Abuse Treat. 2017;78:1–7.
   PubMed Web of Science ®Google Scholar